IOBT IO Biotech Inc: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik iobiotech.com (IOBT)

IO Biotech, Inc. (IOBT) develops advanced immunomodulating vaccines designed to transform the tumor environment and combat cancer. The company implements robotic laboratories and cloud software for genomic data analysis. The business is centered around the T-win ecosystem, featuring unique patents for T-cell activation. The EV/Sales history illustrates the business value-to-revenue trend, where the value remains around 0.00.

Nilai perusahaan marang pendapatan: IO Biotech Inc (IOBT) kanggo 23.11.2025 - 18.04.2026

iobiotech.com - rincian analitis lan metrik utama (IOBT)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:IO Biotech, Inc. IOBT
Sampel barang IO Biotech, Inc.

The enterprise value-to-revenue trajectory reflects the market valuation of the biopharmaceutical potential of IO Biotech, Inc. (IOBT) in the development of cancer therapies. The EV/Sales metric compares the total value of the business with sales volume, excluding the impact of debt load. The calculation is based on the sum of market capitalization and net debt divided by annual revenue. For an innovator with the T-win platform, this indicator measures the premium for future scientific success. This analysis allows for an assessment of whether the current capitalization is fair relative to the R&D stage.

Analisis pesaing IO Biotech, Inc.

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales cgen.com|Rasio nilai perusahaan marang pendapatan Sutro Biopharma (STRO)|INKT: Nilai perusahaan marang volume dodolan|Werewolf Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Immix (IMMX) - Multiplikator nilai perusahaan marang pendapatan|ALX Oncology Holdings Inc. - Multiplikator EV/Sales|CUE - Multiplikator EV/Sales|PDSB: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Liminatus Pharma (LIMN)|Multiplikator EV/Sales LVTX|Koefisien nilai perusahaan marang pendapatan NXTC|Leap Therapeutics, Inc. - Nilai perusahaan marang pendapatan|INTS: Rasio nilai perusahaan marang pendapatan|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP